Prognia
Drug Database
🇪🇺EU · EMAApplication withdrawnATC: L01XE03

Erlotinib Accord

Carcinoma, Non-Small-Cell Lung;Pancreatic Neoplasms

Marketing Authorisation Holder: Accord Healthcare S.L.U.

INN: erlotinib

Indication

Treatment of lung and pancreatic cancers

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Erlotinib Accord — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.